Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis

NCT00612014 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroparesis
Diabetes Mellitus

Interventions

DRUG: 5% dextrose in water
DRUG: TZP-101
DRUG: TZP-101
DRUG: TZP-101
DRUG: TZP-101
DRUG: TZP-101

Sponsor

Tranzyme, Inc.